Tenosynovial Giant Cell Tumor Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 69 pages | ID: T4DAE0BD0627EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Tenosynovial Giant Cell Tumor Treatment in Global, including the following market information:

Global Tenosynovial Giant Cell Tumor Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tenosynovial Giant Cell Tumor Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tenosynovial Giant Cell Tumor Treatment include Novartis International AG, Roche Holding AG, Bristol Myers Squibb Company, Plexxikon, Daiichi Sankyo Company, Limited, Johnson & Johnson, Bayer AG, Pfizer Inc. and Eli Lilly and Company and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tenosynovial Giant Cell Tumor Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tenosynovial Giant Cell Tumor Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tenosynovial Giant Cell Tumor Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Therapy
• Radiation Therapy
• Surgical Operation

Global Tenosynovial Giant Cell Tumor Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tenosynovial Giant Cell Tumor Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Surgical clinics
• Others

Global Tenosynovial Giant Cell Tumor Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tenosynovial Giant Cell Tumor Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tenosynovial Giant Cell Tumor Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tenosynovial Giant Cell Tumor Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis International AG
• Roche Holding AG
• Bristol Myers Squibb Company
• Plexxikon
• Daiichi Sankyo Company, Limited
• Johnson & Johnson
• Bayer AG
• Pfizer Inc.
• Eli Lilly and Company
• Merck & Co.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tenosynovial Giant Cell Tumor Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tenosynovial Giant Cell Tumor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TENOSYNOVIAL GIANT CELL TUMOR TREATMENT OVERALL MARKET SIZE

2.1 Global Tenosynovial Giant Cell Tumor Treatment Market Size: 2021 VS 2028
2.2 Global Tenosynovial Giant Cell Tumor Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tenosynovial Giant Cell Tumor Treatment Players in Global Market
3.2 Top Global Tenosynovial Giant Cell Tumor Treatment Companies Ranked by Revenue
3.3 Global Tenosynovial Giant Cell Tumor Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tenosynovial Giant Cell Tumor Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tenosynovial Giant Cell Tumor Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tenosynovial Giant Cell Tumor Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Tenosynovial Giant Cell Tumor Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tenosynovial Giant Cell Tumor Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tenosynovial Giant Cell Tumor Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Therapy
  4.1.3 Radiation Therapy
  4.1.4 Surgical Operation
4.2 By Type - Global Tenosynovial Giant Cell Tumor Treatment Revenue & Forecasts
  4.2.1 By Type - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tenosynovial Giant Cell Tumor Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Surgical clinics
  5.1.4 Others
5.2 By Application - Global Tenosynovial Giant Cell Tumor Treatment Revenue & Forecasts
  5.2.1 By Application - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tenosynovial Giant Cell Tumor Treatment Market Size, 2021 & 2028
6.2 By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue & Forecasts
  6.2.1 By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028
  6.3.2 US Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.3.3 Canada Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.3.4 Mexico Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028
  6.4.2 Germany Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.3 France Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.4 U.K. Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.5 Italy Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.6 Russia Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.4.8 Benelux Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028
  6.5.2 China Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.5.3 Japan Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.5.4 South Korea Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.5.6 India Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028
  6.6.2 Brazil Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.6.3 Argentina Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028
  6.7.2 Turkey Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.7.3 Israel Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028
  6.7.5 UAE Tenosynovial Giant Cell Tumor Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis International AG
  7.1.1 Novartis International AG Corporate Summary
  7.1.2 Novartis International AG Business Overview
  7.1.3 Novartis International AG Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.1.4 Novartis International AG Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis International AG Key News
7.2 Roche Holding AG
  7.2.1 Roche Holding AG Corporate Summary
  7.2.2 Roche Holding AG Business Overview
  7.2.3 Roche Holding AG Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.2.4 Roche Holding AG Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.2.5 Roche Holding AG Key News
7.3 Bristol Myers Squibb Company
  7.3.1 Bristol Myers Squibb Company Corporate Summary
  7.3.2 Bristol Myers Squibb Company Business Overview
  7.3.3 Bristol Myers Squibb Company Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.3.4 Bristol Myers Squibb Company Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol Myers Squibb Company Key News
7.4 Plexxikon
  7.4.1 Plexxikon Corporate Summary
  7.4.2 Plexxikon Business Overview
  7.4.3 Plexxikon Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.4.4 Plexxikon Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.4.5 Plexxikon Key News
7.5 Daiichi Sankyo Company, Limited
  7.5.1 Daiichi Sankyo Company, Limited Corporate Summary
  7.5.2 Daiichi Sankyo Company, Limited Business Overview
  7.5.3 Daiichi Sankyo Company, Limited Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.5.4 Daiichi Sankyo Company, Limited Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.5.5 Daiichi Sankyo Company, Limited Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.6.4 Johnson & Johnson Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Bayer AG
  7.7.1 Bayer AG Corporate Summary
  7.7.2 Bayer AG Business Overview
  7.7.3 Bayer AG Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.7.4 Bayer AG Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bayer AG Key News
7.8 Pfizer Inc.
  7.8.1 Pfizer Inc. Corporate Summary
  7.8.2 Pfizer Inc. Business Overview
  7.8.3 Pfizer Inc. Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.8.4 Pfizer Inc. Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Inc. Key News
7.9 Eli Lilly and Company
  7.9.1 Eli Lilly and Company Corporate Summary
  7.9.2 Eli Lilly and Company Business Overview
  7.9.3 Eli Lilly and Company Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.9.4 Eli Lilly and Company Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.9.5 Eli Lilly and Company Key News
7.10 Merck & Co.
  7.10.1 Merck & Co. Corporate Summary
  7.10.2 Merck & Co. Business Overview
  7.10.3 Merck & Co. Tenosynovial Giant Cell Tumor Treatment Major Product Offerings
  7.10.4 Merck & Co. Tenosynovial Giant Cell Tumor Treatment Revenue in Global Market (2017-2022)
  7.10.5 Merck & Co. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tenosynovial Giant Cell Tumor Treatment Market Opportunities & Trends in Global Market
Table 2. Tenosynovial Giant Cell Tumor Treatment Market Drivers in Global Market
Table 3. Tenosynovial Giant Cell Tumor Treatment Market Restraints in Global Market
Table 4. Key Players of Tenosynovial Giant Cell Tumor Treatment in Global Market
Table 5. Top Tenosynovial Giant Cell Tumor Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tenosynovial Giant Cell Tumor Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tenosynovial Giant Cell Tumor Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tenosynovial Giant Cell Tumor Treatment Product Type
Table 9. List of Global Tier 1 Tenosynovial Giant Cell Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tenosynovial Giant Cell Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tenosynovial Giant Cell Tumor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tenosynovial Giant Cell Tumor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tenosynovial Giant Cell Tumor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tenosynovial Giant Cell Tumor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis International AG Corporate Summary
Table 31. Novartis International AG Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 32. Novartis International AG Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Roche Holding AG Corporate Summary
Table 34. Roche Holding AG Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 35. Roche Holding AG Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol Myers Squibb Company Corporate Summary
Table 37. Bristol Myers Squibb Company Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 38. Bristol Myers Squibb Company Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Plexxikon Corporate Summary
Table 40. Plexxikon Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 41. Plexxikon Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Daiichi Sankyo Company, Limited Corporate Summary
Table 43. Daiichi Sankyo Company, Limited Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 44. Daiichi Sankyo Company, Limited Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 47. Johnson & Johnson Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 50. Bayer AG Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Inc. Corporate Summary
Table 52. Pfizer Inc. Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 53. Pfizer Inc. Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Eli Lilly and Company Corporate Summary
Table 55. Eli Lilly and Company Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 56. Eli Lilly and Company Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Merck & Co. Corporate Summary
Table 58. Merck & Co. Tenosynovial Giant Cell Tumor Treatment Product Offerings
Table 59. Merck & Co. Tenosynovial Giant Cell Tumor Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tenosynovial Giant Cell Tumor Treatment Segment by Type in 2021
Figure 2. Tenosynovial Giant Cell Tumor Treatment Segment by Application in 2021
Figure 3. Global Tenosynovial Giant Cell Tumor Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tenosynovial Giant Cell Tumor Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tenosynovial Giant Cell Tumor Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tenosynovial Giant Cell Tumor Treatment Revenue in 2021
Figure 8. By Type - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 12. US Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 24. China Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tenosynovial Giant Cell Tumor Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tenosynovial Giant Cell Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis International AG Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Holding AG Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol Myers Squibb Company Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Plexxikon Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Daiichi Sankyo Company, Limited Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Inc. Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eli Lilly and Company Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck & Co. Tenosynovial Giant Cell Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)